BDC Venture Capital made an announcement today and said it would pledge USD135 million to support Canadian entrepreneurs who are in the innovative healthcare market. The private equity firm reportedly saw potential in placing investments in technology, products and services dedicated to improve producticity, patient outcomes and efficiency in healthcare.
Senior Managing Partner of the BDC Venture Capital Healthcare Fund Dion Madsen said, "Great investors typically look for industries that are undergoing massive disruption, and this is certainly true of the healthcare sector. We have never seen a better time to invest in the sector. "All economies are struggling to maintain affordable and accessible healthcare systems. They are seeking new technologies to improve their health systems and improve healthcare delivery, while managing rising costs. With the widespread availability of wireless and mobile technologies, innovative molecular diagnostics and imaging technology, high-throughput genomic sequencing, and innovations in healthcare IT, the opportunity exists to radically transform healthcare delivery across the planet."
BDC Venture Capital is a major venture capital investor based in Canada. It has a total direct commitment of USD270 million to the healthcare sector. It has since recorded successes in its investments in OncoGeneX, ViroChem, Tekmira, Cytochroma and Gemin X.
Join the Conversation